| Literature DB >> 32402306 |
Morgan Bonds1, Flavio G Rocha2.
Abstract
Incidence of neuroendocrine tumors (NETs) is increasing, including those of the gastroenteropancreatic tract. A proper understanding of the management of this disease has become necessary for the general surgeon. This article addresses current guidelines for diagnosis and localization of NETs, including somatostatin receptor PET. Updated treatment and outcomes of NETs by primary tumor site are discussed as well as those metastatic to the liver.Entities:
Keywords: Appendix; Carcinoid; Liver metastases; Neuroendocrine; Pancreas; Small intestine
Mesh:
Substances:
Year: 2020 PMID: 32402306 DOI: 10.1016/j.suc.2020.02.010
Source DB: PubMed Journal: Surg Clin North Am ISSN: 0039-6109 Impact factor: 2.741